Teicoplanin alkalmazása vesetranszplantáltak gram-pozitív infekcióiban.

Translated title of the contribution: The use of teicoplanin for Gram-positive infections in patients with kidney transplantation

J. Jákics, Z. Gálffy, L. Hernold, A. Rácz, F. Perner

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Teicoplanin was used for the treatment of multiresistant Gram-positive-Staphylococcus aureus, coagulase negative Staphylococcus and Enterococcus-infections in 15 cases of kidney transplantations. The motive of the application was the once per day dosage and the spare of the transplanted kidney. Nosocomial infections were the most common. Clinical and microbiological diagnosis was the criteria in order to begin the 5-21 days treatment. These patients which were infected with Gram positive bacteria, teicoplanin was also effective in methicillin-resistant cases. In some mixed infections, after several courses of antibiotics, teicoplanin even if combined with other antibiotics could not prevent fatal sepsis.

Original languageHungarian
Pages (from-to)1355-1358
Number of pages4
JournalOrvosi Hetilap
Volume137
Issue number25
Publication statusPublished - Jun 23 1996

Fingerprint

Teicoplanin
Kidney Transplantation
Infection
Anti-Bacterial Agents
Methicillin Resistance
Coagulase
Enterococcus
Gram-Positive Bacteria
Cross Infection
Coinfection
Staphylococcus
Staphylococcus aureus
Sepsis
Kidney
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Jákics, J., Gálffy, Z., Hernold, L., Rácz, A., & Perner, F. (1996). Teicoplanin alkalmazása vesetranszplantáltak gram-pozitív infekcióiban. Orvosi Hetilap, 137(25), 1355-1358.

Teicoplanin alkalmazása vesetranszplantáltak gram-pozitív infekcióiban. / Jákics, J.; Gálffy, Z.; Hernold, L.; Rácz, A.; Perner, F.

In: Orvosi Hetilap, Vol. 137, No. 25, 23.06.1996, p. 1355-1358.

Research output: Contribution to journalArticle

Jákics, J, Gálffy, Z, Hernold, L, Rácz, A & Perner, F 1996, 'Teicoplanin alkalmazása vesetranszplantáltak gram-pozitív infekcióiban.', Orvosi Hetilap, vol. 137, no. 25, pp. 1355-1358.
Jákics J, Gálffy Z, Hernold L, Rácz A, Perner F. Teicoplanin alkalmazása vesetranszplantáltak gram-pozitív infekcióiban. Orvosi Hetilap. 1996 Jun 23;137(25):1355-1358.
Jákics, J. ; Gálffy, Z. ; Hernold, L. ; Rácz, A. ; Perner, F. / Teicoplanin alkalmazása vesetranszplantáltak gram-pozitív infekcióiban. In: Orvosi Hetilap. 1996 ; Vol. 137, No. 25. pp. 1355-1358.
@article{dd36575577644fc5800e2f26ab0a1627,
title = "Teicoplanin alkalmaz{\'a}sa vesetranszplant{\'a}ltak gram-pozit{\'i}v infekci{\'o}iban.",
abstract = "Teicoplanin was used for the treatment of multiresistant Gram-positive-Staphylococcus aureus, coagulase negative Staphylococcus and Enterococcus-infections in 15 cases of kidney transplantations. The motive of the application was the once per day dosage and the spare of the transplanted kidney. Nosocomial infections were the most common. Clinical and microbiological diagnosis was the criteria in order to begin the 5-21 days treatment. These patients which were infected with Gram positive bacteria, teicoplanin was also effective in methicillin-resistant cases. In some mixed infections, after several courses of antibiotics, teicoplanin even if combined with other antibiotics could not prevent fatal sepsis.",
author = "J. J{\'a}kics and Z. G{\'a}lffy and L. Hernold and A. R{\'a}cz and F. Perner",
year = "1996",
month = "6",
day = "23",
language = "Hungarian",
volume = "137",
pages = "1355--1358",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "25",

}

TY - JOUR

T1 - Teicoplanin alkalmazása vesetranszplantáltak gram-pozitív infekcióiban.

AU - Jákics, J.

AU - Gálffy, Z.

AU - Hernold, L.

AU - Rácz, A.

AU - Perner, F.

PY - 1996/6/23

Y1 - 1996/6/23

N2 - Teicoplanin was used for the treatment of multiresistant Gram-positive-Staphylococcus aureus, coagulase negative Staphylococcus and Enterococcus-infections in 15 cases of kidney transplantations. The motive of the application was the once per day dosage and the spare of the transplanted kidney. Nosocomial infections were the most common. Clinical and microbiological diagnosis was the criteria in order to begin the 5-21 days treatment. These patients which were infected with Gram positive bacteria, teicoplanin was also effective in methicillin-resistant cases. In some mixed infections, after several courses of antibiotics, teicoplanin even if combined with other antibiotics could not prevent fatal sepsis.

AB - Teicoplanin was used for the treatment of multiresistant Gram-positive-Staphylococcus aureus, coagulase negative Staphylococcus and Enterococcus-infections in 15 cases of kidney transplantations. The motive of the application was the once per day dosage and the spare of the transplanted kidney. Nosocomial infections were the most common. Clinical and microbiological diagnosis was the criteria in order to begin the 5-21 days treatment. These patients which were infected with Gram positive bacteria, teicoplanin was also effective in methicillin-resistant cases. In some mixed infections, after several courses of antibiotics, teicoplanin even if combined with other antibiotics could not prevent fatal sepsis.

UR - http://www.scopus.com/inward/record.url?scp=0030598638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030598638&partnerID=8YFLogxK

M3 - Article

C2 - 8757082

AN - SCOPUS:0030598638

VL - 137

SP - 1355

EP - 1358

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 25

ER -